Literature DB >> 9300412

Expression of activating transcription factor-2, serum response factor and cAMP/Ca response element binding protein in the adult rat brain following generalized seizures, nerve fibre lesion and ultraviolet irradiation.

T Herdegen1, A Blume, T Buschmann, E Georgakopoulos, C Winter, W Schmid, T F Hsieh, M Zimmermann, P Gass.   

Abstract

The expression of the constitutive transcription factors activating transcription factor-2 (ATF-2), serum response factor (SRF) and cAMP/Ca response element binding factor (CREB), and the phosphorylation of SRF and CREB were studied in the untreated adult rat nervous system and following seizure activities and neurodegenerative stimuli. In the untreated rat, intense nuclear SRF immunoreactivity was present in the vast majority of neurons in the forebrain, cortex, striatum, amygdala and hippocampus, and in some scattered neurons in the medulla and spinal cord. In contrast, SRF immunoreactivity was absent in the midline areas of the forebrain, e.g., the globus pallidum and septum, and in the hypothalamus, thalamus, mesencephalon and motoneurons. Nuclear ATF-2 was expressed at high levels in apparently all neurons, but not glial cells, throughout the neuraxis except for those neuronal populations which exhibit a high basal level of c-Jun, i.e. dentate gyrus and the motoneurons of cranial and somatosensory neurons. CREB immunoreactivity was present at a rather uniform intensity in all neuronal and glial cells throughout the neuraxis. Two hours, but not 5 h or 24 h, following systemic application of kainic acid, an increase in SRF was detectable by western blot analysis in hippocampal and cortical homogenates whereas the expression of ATF-2 and CREB did not change. Phosphorylation of CREB at serine 133 and of SRF at serine 103 were studied with specific antisera. In untreated rats, intense phosphoCREB and phosphoSRF immunoreactivities labelled many glial cells and/or neurons with the highest levels in the dentate gyrus, the entorhinal cortex and the retrosplenial cortex. Following kainate-induced seizures, phosphoSRF-IR but not phosphoCREB-IR transiently increased between 0.5 h and 2 h. Following transection of peripheral or central nerve fibres such as optic nerve, medial forebrain bundle, vagal and facial nerve fibres, ATF-2 rapidly decreased in the axotomized neurons during that period when c-Jun was rapidly expressed. SRF remained unchanged and CREB disappeared in some axotomized subpopulations. Similar to axotomy, c-Jun increased and ATF-2 decreased in cultured adult dorsal root ganglion neurons following ultraviolet irradiation. The distribution of SRF and ATF-2 suggests that their putative target genes c-fos, junB, krox-24 and c-jun can be independently regulated from SRF and ATF-2. The suppression of ATF-2 and the expression of c-Jun following axotomy and ultraviolet irradiation might be part of a novel neuronal stress response in the brain that strongly resembles the stress response characterized in non-neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300412     DOI: 10.1016/s0306-4522(97)00170-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Minocycline exacerbates apoptotic neurodegeneration induced by the NMDA receptor antagonist MK-801 in the early postnatal mouse brain.

Authors:  Ioana Inta; Miriam A Vogt; Anne S Vogel; Markus Bettendorf; Peter Gass; Dragos Inta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10-19       Impact factor: 5.270

2.  Persistent increased DNA-binding and expression of serum response factor occur with epilepsy-associated long-term plasticity changes.

Authors:  T A Morris; N Jafari; A C Rice; O Vasconcelos; R J DeLorenzo
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

3.  Serum response factor is essential for mesoderm formation during mouse embryogenesis.

Authors:  S Arsenian; B Weinhold; M Oelgeschläger; U Rüther; A Nordheim
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

4.  FOXP3 regulates sensitivity of cancer cells to irradiation by transcriptional repression of BRCA1.

Authors:  Weiquan Li; Hiroto Katoh; Lizhong Wang; Xiaochun Yu; Zhanwen Du; Xiaoli Yan; Pan Zheng; Yang Liu
Journal:  Cancer Res       Date:  2013-01-14       Impact factor: 12.701

5.  Fibroblast growth factor 2 (FGF-2) promotes acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor cells: identification of neural precursors responding to both EGF and FGF-2.

Authors:  F Ciccolini; C N Svendsen
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

6.  Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein.

Authors:  Parvathi Rudrabhatla; Ya-Li Zheng; Niranjana D Amin; Sashi Kesavapany; Wayne Albers; Harish C Pant
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

7.  Dihydrotestosterone activates CREB signaling in cultured hippocampal neurons.

Authors:  Thuy-Vi V Nguyen; Mingzhong Yao; Christian J Pike
Journal:  Brain Res       Date:  2009-08-31       Impact factor: 3.252

8.  The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1.

Authors:  D Perkins; E F R Pereira; L Aurelian
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Loss of ATF2 function leads to cranial motoneuron degeneration during embryonic mouse development.

Authors:  Julien Ackermann; Garry Ashton; Steve Lyons; Dominic James; Jean-Pierre Hornung; Nic Jones; Wolfgang Breitwieser
Journal:  PLoS One       Date:  2011-04-21       Impact factor: 3.240

10.  Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury.

Authors:  T Herdegen; F X Claret; T Kallunki; A Martin-Villalba; C Winter; T Hunter; M Karin
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.